Acuta Capital Partners, LLC Top Holdings and 13F Report (2025) About Acuta Capital Partners, LLCInvestment ActivityAcuta Capital Partners, LLC has $71.64 million in total holdings as of June 30, 2025.Acuta Capital Partners, LLC owns shares of 28 different stocks, but just 13 companies or ETFs make up 80% of its holdings.Approximately 11.34% of the portfolio was purchased this quarter.About 43.01% of the portfolio was sold this quarter.This quarter, Acuta Capital Partners, LLC has purchased 34 new stocks and bought additional shares in 6 stocks.Acuta Capital Partners, LLC sold shares of 13 stocks and completely divested from 10 stocks this quarter.Largest Holdings Ocular Therapeutix $9,418,643CIDARA THERAPEUTICS INC $8,746,806Aadi Bioscience $6,377,452Soleno Therapeutics $5,314,668TOURMALINE BIO INC $4,536,075 Largest New Holdings this Quarter 877619106 - Taysha Gene Therapies $1,121,895 Holding00973Y108 - Akero Therapeutics $1,055,034 Holding359616109 - Fulcrum Therapeutics $410,392 Holding90466Y202 - UNICYCIVE THERAPEUTICS INC $300,028 Holding Largest Purchases this Quarter CIDARA THERAPEUTICS INC 53,861 shares (about $2.62M)Jazz Pharmaceuticals 16,708 shares (about $1.77M)Taysha Gene Therapies 485,669 shares (about $1.12M)Akero Therapeutics 19,772 shares (about $1.06M)Terns Pharmaceuticals 138,314 shares (about $515.91K) Largest Sales this Quarter Insmed 69,004 shares (about $6.94M)TOURMALINE BIO INC 143,200 shares (about $2.29M)Ocular Therapeutix 204,784 shares (about $1.90M)Trevi Therapeutics 292,226 shares (about $1.60M)Liquidia Technologies 77,606 shares (about $966.97K) Sector Allocation Over TimeMap of 500 Largest Holdings ofAcuta Capital Partners, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorOCULOcular Therapeutix$9,418,643$1,900,395 ▼-16.8%1,014,94013.1%MedicalCIDARA THERAPEUTICS INC$8,746,806$2,623,569 ▲42.8%179,56912.2%COM NEWAADIAadi Bioscience$6,377,4520.0%3,410,4028.9%MedicalSLNOSoleno Therapeutics$5,314,668$309,986 ▼-5.5%63,4367.4%MedicalTOURMALINE BIO INC$4,536,075$2,289,768 ▼-33.5%283,6826.3%COMASNDAscendis Pharma A/S$3,896,618$131,866 ▼-3.3%22,5765.4%MedicalINSMInsmed$3,730,725$6,944,563 ▼-65.1%37,0705.2%MedicalARGXargenex$3,694,276$176,942 ▼-4.6%6,7025.2%MedicalPRAXIS PRECISION MEDICINES I$3,115,358$548,921 ▼-15.0%74,0874.3%COMJAZZJazz Pharmaceuticals$2,789,152$1,773,053 ▲174.5%26,2833.9%MedicalTRVITrevi Therapeutics$2,700,730$1,598,476 ▼-37.2%493,7353.8%MedicalOCSOculis$2,071,396$354,854 ▼-14.6%106,7182.9%MedicalRVMDRevolution Medicines$2,048,945$403,549 ▼-16.5%55,6932.9%MedicalHELIX ACQUISITION CORP II$1,988,6690.0%187,2572.8%CL A ORD SHSTERNTerns Pharmaceuticals$1,730,213$515,911 ▲42.5%463,8642.4%MedicalSURROZEN, INC.$1,519,8000.0%170,0002.1%COM NEWBRIGHT MINDS BIOSCIENCES INC$1,265,656$294,364 ▼-18.9%48,4741.8%COM NEWTSHATaysha Gene Therapies$1,121,895$1,121,895 ▲New Holding485,6691.6%MedicalAKROAkero Therapeutics$1,055,034$1,055,034 ▲New Holding19,7721.5%MedicalZYMEZymeworks$1,049,870$190,710 ▲22.2%83,6551.5%MedicalLQDALiquidia Technologies$945,415$966,971 ▼-50.6%75,8761.3%MedicalRAREUltragenyx Pharmaceutical$865,877$91,773 ▲11.9%23,8141.2%MedicalVSTMVerastem$624,218$106,182 ▼-14.5%150,4140.9%MedicalFULCFulcrum Therapeutics$410,392$410,392 ▲New Holding59,6500.6%MedicalUNICYCIVE THERAPEUTICS INC$300,028$300,028 ▲New Holding62,8990.4%COMRAPPORT THERAPEUTICS INC$227,400$40,932 ▲22.0%20,0000.3%COMARTIVA BIOTHERAPEUTICS INC$68,6390.0%45,4560.1%COMNUVATION BIO INC -CW27$24,5160.0%90,8320.0%*W EXP 07/07/2027ELVNEnliven Therapeutics$0$5,220,494 ▼-100.0%00.0%MedicalMRKMerck & Co., Inc.$0$2,063,941 ▼-100.0%00.0%MedicalEWTXEdgewise Therapeutics$0$1,879,988 ▼-100.0%00.0%MedicalMREOMereo BioPharma Group$0$1,781,584 ▼-100.0%00.0%MedicalUNCYUnicycive Therapeutics$0$1,352,675 ▼-100.0%00.0%MedicalGILDGilead Sciences$0$1,041,841 ▼-100.0%00.0%MedicalVERVVerve Therapeutics$0$743,649 ▼-100.0%00.0%MedicalRCKTRocket Pharmaceuticals$0$555,945 ▼-100.0%00.0%MedicalFORTE BIOSCIENCES INC$0$143,319 ▼-100.0%00.0%COM NEWENLIVEN THERAPEUTICS INC$0-100.0%00.0%COMShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access